These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Vaslaki L; Major L; Berta K; Karatson A; Misz M; Pethoe F; Ladanyi E; Fodor B; Stein G; Pischetsrieder M; Zima T; Wojke R; Gauly A; Passlick-Deetjen J Blood Purif; 2006; 24(2):163-73. PubMed ID: 16352871 [TBL] [Abstract][Full Text] [Related]
29. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study. Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064 [TBL] [Abstract][Full Text] [Related]
30. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R; Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316 [TBL] [Abstract][Full Text] [Related]
31. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC). Pizzarelli F; David S; Sala P; Icardi A; Casani A Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298 [TBL] [Abstract][Full Text] [Related]
32. [Oxidative stress analysis in patients on hemodiafiltration on-line]. Torregrosa E; Hernández Jaras J; Sastre J; Pons R; García Calvo H; Calvo Gordo C; Fenollosa MA; Rius A; Sánchez-Canel JJ; Pin M; Tamarit E; Rico I Nefrologia; 2007; 27(5):612-8. PubMed ID: 18045038 [TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of plasma proteins of high-flux haemodialysis and on-line haemodiafiltration patients reveals differences in transthyretin levels related with anaemia. Martínez-Alonso E; Alcázar P; Camafeita E; Fernández-Lucas M; Ruíz-Roso G; Alcázar A Sci Rep; 2020 Sep; 10(1):16029. PubMed ID: 32994444 [TBL] [Abstract][Full Text] [Related]
34. Homocysteine reduction rate in internal haemodiafiltration-a comparison with other mixed dialysis therapies. Righetti M; Ferrario GM; Serbelloni P; Milani S; Tommasi A Nephrol Dial Transplant; 2006 Jul; 21(7):2034-5. PubMed ID: 16524932 [No Abstract] [Full Text] [Related]
35. The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study. Mazairac AH; Blankestijn PJ; Grooteman MP; Penne EL; van der Weerd NC; den Hoedt CH; Buskens E; van den Dorpel MA; ter Wee PM; Nubé MJ; Bots ML; de Wit GA; Nephrol Dial Transplant; 2013 Jul; 28(7):1865-73. PubMed ID: 23766337 [TBL] [Abstract][Full Text] [Related]
36. The impact of dialysis modality on skin hyperpigmentation in haemodialysis patients. Moon SJ; Kim DK; Chang JH; Kim CH; Kim HW; Park SY; Han SH; Lee JE; Yoo TH; Han DS; Kang SW Nephrol Dial Transplant; 2009 Sep; 24(9):2803-9. PubMed ID: 19342419 [TBL] [Abstract][Full Text] [Related]
37. Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients. Paats J; Adoberg A; Arund J; Dhondt A; Fernström A; Fridolin I; Glorieux G; Leis L; Luman M; Gonzalez-Parra E; Perez-Gomez VM; Pilt K; Sanchez-Ospina D; Segelmark M; Uhlin F; Arduan Ortiz A Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102247 [TBL] [Abstract][Full Text] [Related]